Impact of Diabetes Mellitus on Outcomes after High-Risk Interventional Coronary Procedures

Laura Johannsen1, Julian Soldat1, Andrea Krueger1

  • 1Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Hospital Essen, Medical Faculty, 45147 Essen, Germany.

Insights

Diabetes mellitus (DM) did not significantly increase in-hospital adverse events or reduce one-year survival in high-risk patients undergoing percutaneous coronary intervention (PCI). These findings suggest PCI is a viable option for high-risk patients with DM.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Diabetology

Background:

  • High-risk patients with coronary artery disease often face increased operative risks with traditional surgery.
  • Percutaneous coronary intervention (PCI) is an alternative for patients unsuitable for coronary artery bypass grafting (CABG).
  • The impact of diabetes mellitus (DM) on outcomes after high-risk PCI requires further investigation.

Purpose of the Study:

  • To evaluate the outcomes of patients with DM undergoing high-risk PCI.
  • To compare in-hospital major adverse cardiac and cerebrovascular events (MACCEs) and one-year survival between diabetic and non-diabetic patients.

Main Methods:

  • Retrospective analysis of consecutive high-risk PCI patients from January 2016 to August 2018.
  • Assessment of in-hospital MACCEs (stroke, myocardial infarction, death) and one-year all-cause mortality.
  • Comparison of outcomes between patients with and without DM.

Main Results:

  • A total of 276 patients underwent high-risk PCI; 31% had DM.
  • In-hospital MACCEs occurred in 6% of DM patients versus 2% of non-DM patients (p=0.24).
  • One-year survival rates were 87.1% for DM patients and 93.6% for non-DM patients (p=0.07), with no significant difference based on coronary complexity.

Conclusions:

  • In selected high-risk patients, DM was not associated with significantly increased in-hospital MACCEs after high-risk PCI.
  • One-year survival rates were comparable between diabetic and non-diabetic patients undergoing high-risk PCI.
  • High-risk PCI appears to be a safe and effective revascularization strategy for patients with DM and complex coronary artery disease.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
145
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
704
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.5K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
646
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.8K